General Assembly Raised Bill No. 1084
January Session, 2011 LCO No. 3589
*_____SB01084INS___031611____*
Referred to Committee on Insurance and Real Estate
Introduced by:
(INS)
General Assembly
Raised Bill No. 1084
January Session, 2011
LCO No. 3589
*_____SB01084INS___031611____*
Referred to Committee on Insurance and Real Estate
Introduced by:
(INS)
AN ACT CONCERNING OUT-OF-POCKET EXPENSES FOR NONPREFERRED BRAND NAME DRUGS.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. (NEW) (Effective January 1, 2012) No insurer, fraternal benefit society, hospital service corporation, medical service corporation, health care center or other entity that delivers, issues for delivery, renews, amends or continues in this state an individual health insurance policy that provides coverage for prescription drugs shall impose a coinsurance, copayment, deductible or other out-of-pocket expense for nonpreferred brand name drugs that places a greater financial burden on an insured than for preferred brand name drugs.
Sec. 2. (NEW) (Effective January 1, 2012) No insurer, fraternal benefit society, hospital service corporation, medical service corporation, health care center or other entity that delivers, issues for delivery, renews, amends or continues in this state a group health insurance policy that provides coverage for prescription drugs shall impose a coinsurance, copayment, deductible or other out-of-pocket expense for nonpreferred brand name drugs that places a greater financial burden on an insured than for preferred brand name drugs.
This act shall take effect as follows and shall amend the following sections:
Section 1 January 1, 2012 New section
Sec. 2 January 1, 2012 New section
This act shall take effect as follows and shall amend the following sections:
Section 1
January 1, 2012
New section
Sec. 2
January 1, 2012
New section
INS Joint Favorable
INS
Joint Favorable